Mayo Clinic and the National Cancer Institute Collaborate to Develop and Study Cancer Models of Key Tumorigenesis Pathway Involved in Drug Resistance

Posted on December 9th, 2009 by Kelley Luckstein

The National Cancer Institute and its operations and technical support contractor SAIC-Frederick, Inc. have entered into a research and development collaboration with Mayo Clinic to expand on recent research discoveries at Mayo, where researchers have demonstrated the importance of a key protein involved in pancreatic and lung cancer.

 

PharmaLive, 12/8/09

Tags: Business Relations, Inc, Lung Cancer, pancreatic cancer, SAIC-Frederick, Tumorigenesis

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy